Study of the Penumbra Coil 400 System to Treat Aneurysm
Study of the Penumbra Coil 400 System to Treat Aneurysm
This is a prospective, multi-center study of patients with intracranial or peripheral
 aneurysms who are treated by the PC 400 System. The primary objective is to gather post
 market data on the Penumbra Coil 400 (PC 400) System in the acute treatment of intracranial
 and peripheral aneurysms. Approximately 2,000 patients with intracranial or peripheral
 aneurysms treated by the PC 400 System at up to 100 centers will be enrolled. Data for each
 patient are collected up to discharge or 3 days post-procedure, whichever occurs sooner. Long
 term follow-up to one year will be conducted in accordance to the standard of care at each
 participating hospital.
Inclusion Criteria:

 Patients enrolled in this study must be those treated according to the cleared indication
 for the PC 400 System which is for the endovascular embolization of:

 -  Intracranial aneurysms

 -  Other neurovascular abnormalities such as arteriovenous malformations and
 arteriovenous fistulae

 -  Arterial and venous embolizations in the peripheral vasculature

 Exclusion Criteria:

 -  Patients in whom endovascular embolization therapies other than Penumbra Coils are
 used will be excluded from this study. However, adjunctive use of balloon and stent
 are acceptable.